Company Filing History:
Years Active: 2017
Title: Lorna Kategaya: Innovator in Cancer Treatment
Introduction
Lorna Kategaya is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer and immune disorders.
Latest Patents
Lorna Kategaya holds a patent for USP7 inhibitor compounds and methods of use. Her invention includes 2-Aminopyridine compounds of Formula I, which are designed to modulate USP7. These compounds are useful for treating cancer and immune disorders, including inflammation mediated by USP7. The patent also discloses methods for using these compounds in vitro, in situ, and in vivo for diagnosis and treatment of related disorders in mammalian cells.
Career Highlights
Throughout her career, Lorna has worked with notable companies such as Genentech, Inc. and F. Hoffmann-La Roche AG. Her experience in these leading pharmaceutical companies has allowed her to contribute to groundbreaking research and development in the field.
Collaborations
Lorna has collaborated with esteemed colleagues, including Robert Anthony Blake and Paola Di Lello. These partnerships have further enhanced her work and impact in the industry.
Conclusion
Lorna Kategaya is a trailblazer in the pharmaceutical industry, with her innovative work paving the way for new treatments in cancer and immune disorders. Her contributions are invaluable and continue to influence the field significantly.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.